Seeking Alpha

Retrophin to offer shares

  • Retrophin (RTRX) announces a $40M public offering.
  • The company plans to use the proceeds "to obtain regulatory approval for the reintroduction of Syntocinon into the U.S. market," among other things. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)